Trial data doesn’t “impact” Thailand’s plans to use Sinovac Covid-19 vaccine

Trial data doesn’t “impact” Thailand’s plans to use Sinovac Covid-19 vaccine

Trial data doesn’t “impact” Thailand’s plans to use Sinovac Covid-19 vaccine | The Thaiger

Questions have risen around the vaccine’s efficacy rate, which was originally reported as 78% in trails in Brazil, but recently downgraded to just over 50%. The news comes just as Indonesia is rolling out a mass vaccination campaign with President Joko Widodo injected with the China-made vaccine today.

In Thailand, the news of the low efficiency doesn’t impact the country’s plan to administer the Sinovac Covid-19 vaccine, according to Supakit.

“There is no impact on our plan right now… We are asking for information directly from Sinovac, so we are waiting for their response to get all the facts.”

Thailand ordered 2 million doses of Sinovac’s CoronaVac in the midst of a new wave of coronavirus infections. The first batch of 200,000 doses will arrive next month.

Another 61 million doses of the AstraZeneca vaccine have already been secured and the Thai company Siam Bioscience will produce the vaccine for both domestic use and to export across Southeast Asia.

All vaccines will be assessed based on quality, safety and efficiency, according to Thailand’s Food and Drug Administration.

SOURCE: Reuters

 11,852 ,  3 

No Comments Yet

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Siam Scope Magazine